Lifecare Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Lifecare hat ein Gesamteigenkapital von NOK84.9M und eine Gesamtverschuldung von NOK0.0, was einen Verschuldungsgrad von 0% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen NOK131.7M bzw. NOK46.8M.

Wichtige Informationen

Verhältnis von Schulden zu Eigenkapital

NOK 0

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	NOK 75.89m
Eigenkapital	NOK 84.94m
Gesamtverbindlichkeiten	NOK 46.79m
Gesamtvermögen	NOK 131.72m

Jüngste Berichte zur Finanzlage

We Think Lifecare (OB:LIFE) Can Afford To Drive Business Growth

Sep 13

We're Interested To See How Lifecare (OB:LIFE) Uses Its Cash Hoard To Grow

Apr 30

Recent updates

We Think Lifecare (OB:LIFE) Can Afford To Drive Business Growth

Sep 13

We're Interested To See How Lifecare (OB:LIFE) Uses Its Cash Hoard To Grow

Apr 30

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: LIFEDie kurzfristigen Aktiva des Unternehmens (NOK93.7M) übersteigen seine kurzfristigen Passiva (NOK37.5M).

Langfristige Verbindlichkeiten: LIFEDie kurzfristigen Vermögenswerte des Unternehmens (NOK93.7M) übersteigen seine langfristigen Verbindlichkeiten (NOK9.3M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: LIFE ist schuldenfrei.

Schulden abbauen: LIFE hatte vor 5 Jahren keine Schulden.

Bilanz

Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: LIFE auf der Grundlage seines derzeitigen freier Cashflows über eine ausreichende Liquiditätsreserve für mehr als ein Jahr verfügt.

Vorhersage Cash Runway: LIFE verfügt über eine ausreichende Liquiditätsreserve für 1 Jahre, wenn der freie Cashflow weiterhin mit historischen Raten von 34.9% pro Jahr abnimmt.

Lifecare Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

We Think Lifecare (OB:LIFE) Can Afford To Drive Business Growth

We're Interested To See How Lifecare (OB:LIFE) Uses Its Cash Hoard To Grow

Recent updates

Price target decreased by 13% to kr31.00

Third quarter 2024 earnings released: kr1.07 loss per share (vs kr0.78 loss in 3Q 2023)

Price target decreased by 8.0% to kr34.50

Lifecare AS to Report Q1, 2025 Results on May 15, 2025

Lifecare AS to Report Fiscal Year 2024 Results on Mar 28, 2025

Price target decreased by 31% to kr37.50

Lifecare ASA Announces Biopsies and Bacteriological Existing Implant

Lifecare AS has filed a Follow-on Equity Offering in the amount of NOK 20 million.

Price target decreased by 20% to kr47.00

New major risk - Market cap size

Lifecare AS (OB:LIFE) commences an Equity Buyback Plan, under the authorization approved on September 17, 2024.

We Think Lifecare (OB:LIFE) Can Afford To Drive Business Growth

Lifecare AS Announces Successful Completion of the First Veterinary Patient of the Life Life Trial

New major risk - Shareholder dilution

Lifecare AS has completed a Follow-on Equity Offering in the amount of NOK 90 million.

Lifecare AS Files Application for a New Patent

Lifecare AS Announces Successful Pilot Production

Lifecare AS has filed a Follow-on Equity Offering in the amount of NOK 90 million.

Full year 2023 earnings released: kr0.29 loss per share (vs kr0.17 loss in FY 2022)

Full year 2023 earnings released: kr0.27 loss per share (vs kr0.15 loss in FY 2022)

Lifecare AS Appoints Renete Kaarvik as Chief Financial Officer, Effective 1 Mai 2024

Lifecare AS Announces Appointment of Tony James to Its Scientific Advisory Board

Lifecare AS, Annual General Meeting, Apr 30, 2024

New minor risk - Shareholder dilution

Lifecare AS Announces the Norwegian Food Safety Authority Receives Approval to Start LFC-SEN-002

Lifecare AS has completed a Follow-on Equity Offering in the amount of NOK 42.5 million.

New major risk - Financial position

Lifecare AS to Report Q1, 2023 Results on May 10, 2023

No independent directors

Lifecare AS Announces Interim Data Analysis of the First In-Human Study

Lifecare as Initiates Clinical Studies of the Smallest Glucose Sensor in the Worldr People Diagnosed with Diabeabetes

Chief Executive Officer recently bought kr75k worth of stock

No independent directors

Lifecare AS (OB:LIFE) signed a term sheet agreement to acquire PFÜTZNER Science & Health Institute GmbH for €1.18 million.

Lifecare AS (OB:LIFE) acquired Cantimed Ug (Haftungsbeschrsnkt) from NanoScale Systems Gmbh for €0.65 million.

Chairman of the Board Christian Hysing-Dahl has left the company

We're Interested To See How Lifecare (OB:LIFE) Uses Its Cash Hoard To Grow

Lifecare AS to Report Fiscal Year 2020 Results on Apr 20, 2021

New 90-day high: kr6.40

New 90-day low: kr3.62

Lifecare AS Announces Board Appointments

New 90-day low: kr4.00

Lifecare Receives EUR 3.9 Million from the EU Commission for Development of Bionic Invisible Pancreas to Forgetdiabetes

New 90-day high: kr7.00

Chief Scientific Officer recently sold kr270k worth of stock

Lifecare Appoints Joacim Holter as CEO

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Liquiditätsreserve-Analyse

Entdecken Sie finanziell stabile Unternehmen